New York, USA, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Chronic and Acute Pain Clinical Trial Pipeline Analysis: 150+ Key Companies Shaping the Future of Chronic and Acute Pain Therapeutics | DelveInsight ...
The "NovoCure Ltd (NVCR) - Product Pipeline Analysis, 2025 Update" company profile has been added to ResearchAndMarkets.com's offering. This report is a source for data, analysis, and actionable ...
More than 100 therapies for idiopathic pulmonary fibrosis are being developed across the globe. IPF is a chronic and progressive lung disease that affects the tissue surrounding the air sacs in the ...
Pipeline defect analysis and assessment remains a critical area of research, given its direct impact on the safety and reliability of energy transportation infrastructures. Mechanical defects such as ...
Pipeline MLP Industry Analysis: High Yields And 20%+ Total Return Potential With Plains All American
The company is selling its Canadian NGL (natural gas liquids) business for about $2.9B, reducing the volatility associated with natural gas prices and demand, allowing it to focus on its core ...
Companies Making Up to 35% Return on Investment; More Pipelines Drive Consumer Costs Up, Not Down Washington – A new report from the advocacy organization Food & Water Watch illuminates internal ...
The chronic and acute pain clinical trial analysis report delivers important insights into ongoing research of 200+ pipeline chronic and acute pain drugs, clinical strategies, upcoming therapeutics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results